The Latest

Abuse-Deterrent Opioid Rexista Makes Misusers Blue—LiterallyHow one opioid abuse deterrent could make it easy to identify misuse.
Safinamide (Xadago): Approved as Add-On for Parkinson’sXadago has been approved as a supplementary medication for patients with Parkinson's disease who are having "off" episodes or whose disease is progressing.
Autoimmune Drug Market Could Take OffWhy the market is expecting such significant growth (and how pharmacists can keep their patients in the huge market).
BP Control in Cardiac Surgery: Nitroprusside AlternativesPharmacists must find good alternative therapeutic substitutions for sodium nitroprusside in the face of price gouging and drug shortages.
Development Soars for Alzheimer’s DrugsThere is lots of room for both success and failure in the Alzheimer's drug market.
How Diabetic Kids and Teens Can Improve Quality of LifeGood glucose control can help children and teens with type 1 diabetes boost their quality of life.
FDA Orders Stop Sale of PainkillerThe first opioid taken off the shelves because of potential abuse.
Pharmacist Intervention Improves Diabetes Drug TrialsInterventions by pharmacists can help improve the results of diabetes clinical trials.
Staff Burnout Rates are High at Pharmacy SchoolsA study found that pharmacy practice faculty experience high rates of emotional exhaustion.
Pharmacy Groups Warn Trump About Drug ImportsNACDS and APhA warn that letting Americans buy foreign drugs could be disastrous.